Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Pharmagreen Biotech Inc. (PHBI)
OTHER OTC:PHBI
Holding PHBI?
Track your performance easily
PHBI Stock Chart & Stats
Day’s RangeN/A
52-Week Range― - ―
Previous CloseN/A
Volume191.24K
Average Volume (3M)2.95M
Market Cap
$1.63M
Enterprise Value$838.78K
Total Cash (Recent Filing)$0.00
Total Debt (Recent Filing)$2.78K
Price to Earnings (P/E)―
Beta-0.13
Next Earnings
Dec 19, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)>-0.01
Shares Outstanding663,645,750
10 Day Avg. Volume5,510,897
30 Day Avg. Volume2,949,013
Standard Deviation0.59
R-Squared0.03
Alpha-0.01
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)486.54
Price to Cash Flow (P/CF)390.20
P/FCF Ratio44.30
Enterprise Value/Market Cap0.52
Enterprise Value/Revenue245.98
Enterprise Value/Gross Profit483.17
Enterprise Value/Ebitda-0.86
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
PHBI FAQ
What was Pharmagreen Biotech Inc.’s price range in the past 12 months?
Currently, no data Available
What is Pharmagreen Biotech Inc.’s market cap?
Pharmagreen Biotech Inc.’s market cap is $1.63M.
When is Pharmagreen Biotech Inc.’s upcoming earnings report date?
Pharmagreen Biotech Inc.’s upcoming earnings report date is Dec 19, 2025 which is in 321 days.
How were Pharmagreen Biotech Inc.’s earnings last quarter?
Pharmagreen Biotech Inc. released its earnings results on Sep 02, 2024. The company reported $0 earnings per share for the quarter, the consensus estimate of N/A by $0.
Is Pharmagreen Biotech Inc. overvalued?
According to Wall Street analysts Pharmagreen Biotech Inc.’s price is currently Overvalued.
Does Pharmagreen Biotech Inc. pay dividends?
Pharmagreen Biotech Inc. does not currently pay dividends.
What is Pharmagreen Biotech Inc.’s EPS estimate?
Pharmagreen Biotech Inc.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Pharmagreen Biotech Inc. have?
Pharmagreen Biotech Inc. has 663,645,750 shares outstanding.
What happened to Pharmagreen Biotech Inc.’s price movement after its last earnings report?
Pharmagreen Biotech Inc. reported an EPS of $0 in its last earnings report, expectations of N/A. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Pharmagreen Biotech Inc.?
Currently, no hedge funds are holding shares in PHBI
---
Company Description
Pharmagreen Biotech Inc.
Pharmagreen Biotech, Inc. is a biotech sciences company with specialized products and services in the booming cannabis industry. The firm's products focus on manufacturing and marketing of cannabis products for medical and recreational markets. Its services include Good Manufacturing Practices (GMP) certification for its Tissue Culture facilities, Cold Storage of plantlets as well as Nurseries. The company was founded on November 26, 2007 and is headquartered in Coquitlam, Canada.
---
Scotts Miracle-Gro Company
―
Cronos Group
―
GrowGeneration
―
Tilray
―
Curaleaf Holdings
―
---